09:11 AM EDT, 06/27/2025 (MT Newswires) -- Health care stocks were edging higher premarket Friday with the Health Care Select Sector SPDR Fund ( XLV ) up 0.1% and the iShares Biotechnology ETF (IBB) recently advancing by 0.3%.

Ultragenyx Pharmaceutical ( RARE ) shares were up more than 3% after the company said the US Food and Drug Administration granted breakthrough therapy designation to GTX-102 as a treatment for Angelman syndrome.

BioCryst Pharmaceuticals ( BCRX ) shares were up more than 4% after the company said it has agreed to sell its European Orladeyo business to Neopharmed Gentili for up to $264 million.

CorMedix ( CRMD ) shares were down more than 14% after the company said it has priced an underwritten public offering of about 6.6 million shares for expected gross proceeds of about $85 million.